A clinical study of Fournier’s gangrene tertiary care center government medical college, Nizamabad
Keywords:
Fournier’s Gangrene, management, predisposing factorAbstract
Background: Fournier's gangrene (FG) is fast-spreading necrotizing gangrene that affects the perineum, perianal, and genital regions, but spares the testicles, bladder, and rectum due to their independent blood supply from the aorta. The purpose of this research is to share our experience managing 32 cases. Patients and method: Between April 2018 and May 2022, researchers from Government Medical College in Nizamabad conducted a prospective cross-sectional study of patients with FG. During the study period, all individuals diagnosed with FG and treated for it were included. Age, sex, hospital stay, premorbid conditions, mobility, mortality, laboratory examinations, and therapies performed are among the data collected from these. Results: A total of 38 patients were seen throughout the study, with four patients being eliminated due to missing data, leaving 32 patients for the final analysis. With a male to female ratio of 15:1, there were 30 (93.75%) males and 2 (6.25%) females.
Downloads
References
Montrief T, Long B, Koyfman A, Auerbach J. Fournier gangrene: a review for emergency clinicians. The Journal of Emergency Medicine. 2019;57(4):488-500.
Hutajulu DR, Rizkyansyah HF. Diagnosis and Treatment of Fournier Gangrene in Secondary Hospital; A Report of Two Cases. Journal Research of Social, Science, Economics, and Management. 2021;1(5):492-501.
Rajinikanth.M, Syam Sundar J. a clinical study of fournier's gangrene. Indian Journal of Applied Research. 2019/ 8(11):146-148.
Faiez B, Farouk E, Ibtissem K, Amina C, Faouzi N, Khadija Z. Fournier’s gangrene: its management remains a challenge. The Pan African Medical Journal. 2021;38.
Sarkis P, Farran F, Khoury R, Kamel G, Nemr E, Biajini J, Merheje S. Fournier's gangrene: a review of the recent literature. Progres en Urologie: Journal de L'association Francaise D'urologie et de la Societe Francaise D'urologie. 2008 Nov;19(2):75-84.
Chalya PL, Igenge JZ, Mabula JB, Simbila S. Fournier’s gangrene at a tertiary health facility in northwestern Tanzania: a single centre experiences with 84 patients. BMC research notes. 2015;8(1):1-7.
Agwu NP, Muhammad AS, Abdullahi AA, Bashir B, Legbo JN, Mungadi IA. Pattern and outcome of management of Fournier's gangrene in a resource-constraint setting. Urology Annals. 2020;12(3):248.
Girieasen MS, Viswanathan N, Nedunchezhian S, Ross K. Extensive fournier gangrene with retroperitoneal involvement in a diabetic patient. International Surgery Journal. 2020 ;7(5):1675-8.
Mehl AA, Nogueira Filho DC, Mantovani LM, Grippa MM, Berger R, Krauss D, Ribas D. Management of Fournier's gangrene: experience of a university hospital of Curitiba. Revista do Colegio Brasileiro de Cirurgioes. 2010;37:435-41.
Louro JM, Albano M, Baltazar J, Vaz M, Diogo C, Ramos S, Cabral L. Fournier’s gangrene: 10-year experience of a plastic surgery and burns department at a tertiary hospital. Acta Médica Portuguesa. 2019;32(5):368-74.
Sarofim M, Di Re A, Descallar J, Toh JW. Relationship between diversional stoma and mortality rate in Fournier’s gangrene: a systematic review and meta-analysis. Langenbeck's Archives of Surgery. 2021:1-0.
Lewis GD, Majeed M, Olang CA, Patel A, Gorantla VR, Davis N, Gluschitz S. Fournier’s Gangrene Diagnosis and Treatment: A Systematic Review. Cureus. 2021;13(10).
Sunderkötter C, Becker K, Eckmann C, Graninger W, Kujath P, Schöfer H. Calculated initial parenteral treatment of bacterial infections: Skin and soft tissue infections. GMS Infectious Diseases. 2020;8.
Arora A, Rege S, Surpam S, Gothwal K, Narwade A. Predicting mortality in Fournier gangrene and validating the Fournier Gangrene Severity Index: our experience with 50 patients in a tertiary Care Center in India. Urologia Internationalis. 2019;102(3):311-8.
Raizandha MA, Hidayatullah F, Kloping YP, Rizaldi F. Neutrophil-lymphocyte ratio and fournier gangrene severity index are not prognostic factors of mortality in fournier gangrene patients. Universa Medicina. 2022;41(1):71-8.
Çomçalı B, Ceylan C, Özdemir BA, Ağaçkıran İ, Akıncı F. Comparison of the newly developed Fournier’s gangrene mortality prediction model with existing models. Ulus Travma Acil Cerrahi Derg. 2022;28(4):490-7.
Eray IC, Dalci K, Gumus S, Yalav O, Saritas AG, Boz A, Rencuzogullari A. The role of C-reactive protein ratio in predicting mortality in patients with Fournier gangrene. Ann Coloproctol. 2022.
Benjelloun EB, Souiki T, Yakla N, Ousadden A, Mazaz K, Louchi A, Kanjaa N, Taleb KA. Fournier’s gangrene: our experience with 50 patients and analysis of factors affecting mortality. World Journal of Emergency Surgery. 2013;8(1):1-5.
Sorensen MD, Krieger JN. Fournier's gangrene: epidemiology and outcomes in the general US population. Urologia internationalis. 2016;97(3):249-59.
Chalya PL, Igenge JZ, Mabula JB, Simbila S. Fournier’s gangrene at a tertiary health facility in northwestern Tanzania: a single centre experiences with 84 patients. BMC research notes. 2015;8(1):1-7.
Narayan N, Shivaiah RH, Gowda SN. Fournier’s Gangrene–Management in Rural Tertiary Centre. Highlights on Medicine and Medical Science Vol. 16. 2021:66-81.
Taken K, Oncu MR, Ergun M, Eryilmaz R, Demir CY, Demir M, Gunes M. Fournier’s gangrene: Causes, presentation and survival of sixty-five patients. Pakistan Journal of Medical Sciences. 2016;32(3):746.
Murthy VS, Sudhakar W, Podili NK, Adusumalli RS. fournier's gangrene: experience in a tertiary care hospital--a retrospective analysis of 288 patients. Journal of Evolution of Medical and Dental Sciences. 2017 Dec 4;6(92):6566-70.
Unal B, Kocer B, Ozel E, Bozkurt B, Yildirim O, Altun B, Dolapci M, Cengiz O. Fournier gangrene. Approaches to diagnosis and treatment. Saudi medical journal. 2006;27(7):1038-43.
Cai T, Verze P, Brugnolli A, Tiscione D, Luciani LG, Eccher C, Lanzafame P, Malossini G, Wagenlehner FM, Mirone V, Johansen TE. Adherence to European Association of Urology guidelines on prophylactic antibiotics: an important step in antimicrobial stewardship. European Urology. 2016;69(2):276-83.
Uluğ M, Gedik E, Girgin S, Çelen MK, Ayaz C. The evaluation of microbiology and Fournier's gangrene severity index in 27 patients. International Journal of Infectious Diseases. 2009;13(6):e424-30.
Levenson RB, Singh AK, Novelline RA. Fournier gangrene: role of imaging. Radiographics. 2008;28(2):519-28.
Eke N. Fournier's gangrene: a review of 1726 cases. British Journal of Surgery. 2000;87(6):718-28.
Thwaini A, Khan A, Malik A, Cherian J, Barua J, Shergill I, Mammen K. Fournier’s gangrene and its emergency management. Postgraduate medical journal. 2006;82(970):516-9.
Elsaket AE, Maharajh S, Urry RJ. The presentation, management and outcomes of Fournier’s gangrene at a tertiary urology referral centre in South Africa. South African Medical Journal. 2018;108(8).
Furr J, Watts T, Street R, Cross B, Slobodov G, Patel S. Contemporary trends in the inpatient management of Fournier's gangrene: Predictors of length of stay and mortality based on population-based sample. Urology. 2017 ;102:79-84.
Nyandra, M., Suryasa, W. (2018). Holistic approach to help sexual dysfunction. Eurasian Journal of Analytical Chemistry, 13(3), pp. 207–212.
Rinartha, K., & Suryasa, W. (2017). Comparative study for better result on query suggestion of article searching with MySQL pattern matching and Jaccard similarity. In 2017 5th International Conference on Cyber and IT Service Management (CITSM) (pp. 1-4). IEEE.
Mukhtar, A. U. S., Budu, B., Sanusi B, Y., Mappawere, N. A., & Azniah, A. (2022). The effect of reproductive health education with multimedia video learning on the improvement of fluor albus prevention behavior young woman pathologist. International Journal of Health & Medical Sciences, 5(1), 75-79. https://doi.org/10.21744/ijhms.v5n1.1841
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
